Vanderbilt Heart and Vascular Institute Archives
Feb. 23, 2017—When Jessica Biggs first met Esther Kim, M.D., associate professor of Medicine at Vanderbilt, the 33-year-old burst into tears.
Feb. 15, 2017—The Love Your Heart Expo is scheduled From 10:30 a.m. to 1 p.m. Wednesday, Feb. 22, in the Light Hall North Lobby.
Feb. 9, 2017—Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia.
Jan. 5, 2017—With the recent opening of the Vanderbilt Marfan Syndrome and Aortic Disorders Center, the state’s only comprehensive clinic serving entire families, hundreds of patients with connective tissue disorders now have a one-stop shop for health care.
Oct. 27, 2016—In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.
Aug. 25, 2016—Peggy Tubb doesn’t recall her exact reaction when she was told she could stop taking blood thinners to treat atrial fibrillation (AF), but the news changed her life.
Aug. 18, 2016—The old adage that age is just a number actually became a lifesaver for 71-year-old Rex Parton.
Aug. 4, 2016—Vanderbilt University Medical Center’s heart transplant program is ranked No. 2 nationwide in volume for its combined adult and pediatric procedures, according to the most recent data released by Organ Procurement and Transplant Network (OPTN) in July.
Feb. 18, 2016—Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant.
Nov. 5, 2015—After serving in an interim capacity, Walter Clair, M.D., MPH, associate professor of Medicine and medical director of Cardiac Electrophysiology, has been named executive medical director of the Vanderbilt Heart and Vascular Institute (VHVI).